MEI Pharma Company Profile (NASDAQ:MEIP)

About MEI Pharma

MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the treatment of advanced hematologic diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ME-344 is an isoflavone-based mitochondrial inhibitor targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. PWT143 is an oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that plays a critical role in the proliferation and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase I and Phase II clinical trials in advanced hematologic malignancies and solid tumor indications.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drug Manufacturers - Other
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: MEIP
CUSIP:

Key Metrics:

Previous Close: $1.74
50 Day Moving Average: $1.86
200 Day Moving Average: $1.51
52-Week Range: $0.87 - $2.28
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -3.00
P/E Growth: 40.20
Market Cap: $63.98M
Outstanding Shares: 36,772,000
Beta: 0.57

Profitability:

Return on Equity: -42.55%
Return on Assets: -39.33%

Debt:

Current Ratio: 8.48%
Quick Ratio: 8.48%

Additional Links:

Companies Related to MEI Pharma:

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)

Ratings Breakdown:	1 Hold Rating, 1 Buy Rating
Consensus Rating:	Buy (Score: 2.50)
Consensus Price Target:	$2.00 (14.94% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)

Show:

Date	Firm	Action	Rating	Price Target
8/2/2016	Wedbush	Reiterated Rating	Neutral	$2.00
10/7/2015	Cowen and Company	Reiterated Rating	Buy
9/2/2015	Cantor Fitzgerald	Reiterated Rating	Buy
3/24/2015	Bank of America Corp.	Downgrade	Buy -> Neutral
3/24/2015	Wells Fargo & Co.	Downgrade	Outperform -> Market Perform	$2.25 -> $2.00
3/23/2015	Stifel Nicolaus	Downgrade	Buy -> Hold
3/23/2015	Roth Capital	Downgrade	Buy -> Neutral	$14.00 -> $2.50

(Data available from 9/28/2014 forward)

Earnings History for MEI Pharma (NASDAQ:MEIP)

Date	Consensus Estimate	Actual EPS	Release Link	Conference Call
9/6/2016
9/6/2016	($0.20)	($0.17)	View	N/A
9/2/2015	($0.23)	($0.17)	View	N/A
9/10/2014	($0.37)	($0.40)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for MEI Pharma (NASDAQ:MEIP)

Current Year EPS Consensus Estimate: $-0.57 EPS
Next Year EPS Consensus Estimate: $-0.58 EPS

Dividend History for MEI Pharma (NASDAQ:MEIP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MEI Pharma (NASDAQ:MEIP)

Insider Ownership Percentage: 3.14%
Institutional Ownership Percentage: 20.75%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
11/9/2015	Vivo Ventures Vii, Llc	Major Shareholder	Sell	390,572	$1.84	$718,652.48
1/21/2015	Charles V Baltic III	Director	Buy	5,000	$3.81	$19,050.00
12/9/2014	Leaf Ventures Ii L.P. New	Major Shareholder	Sell	79,085	$6.01	$475,300.85
12/8/2014	Leaf Ventures Ii L.P. New	Major Shareholder	Sell	9,004	$6.05	$54,474.20
6/30/2014	Charles V Baltic III	Director	Buy	2,000	$6.56	$13,120.00
10/29/2013	Vivo Ventures Vii, Llc	Major Shareholder	Sell	299,609	$8.21	$2,459,789.89
10/2/2013	Vivo Ventures Vii, Llc	Major Shareholder	Sell	581,646	$10.16	$5,909,523.36
8/16/2013	Charles V Baltic III	Director	Buy	2,600	$6.82	$17,732.00
6/28/2013	Vivo Ventures Vii, Llc	Major Shareholder	Sell	7,337	$7.58	$55,614.46
6/11/2013	Vivo Ventures V, Llc	Major Shareholder	Sell	13,727	$7.80	$107,070.60
5/16/2013	Vivo Ventures Vii, Llc	Major Shareholder	Sell	17,428	$9.07	$158,071.96
5/8/2013	Leaf Ventures Ii L.P. New	Major Shareholder	Sell	200,000	$8.58	$1,716,000.00
1/25/2013	Charles V Baltic III	Director	Buy	10,200	$6.04	$61,608.00
12/21/2012	Charles V Baltic III	Director	Buy	3,500	$7.18	$25,130.00

(Data available from 1/1/2013 forward)

Latest Headlines for MEI Pharma (NASDAQ:MEIP)

Date	Headline
	Under the Microscope, Zeroing in at MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP) www.duncanindependent.com - September 23 at 10:48 AM
	Penny Stock Investors Keen on Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP) www.duncanindependent.com - September 22 at 10:53 AM
	MEI Pharma, Inc. :MEIP-US: Earnings Analysis: Q4, 2016 By the Numbers : September 21, 2016 (NASDAQ:MEIP) www.capitalcube.com - September 21 at 5:48 PM
	Stock Update, a Closer Look at MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP) www.duncanindependent.com - September 16 at 5:55 PM
	Keen Investors Seek Information on MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP) www.duncanindependent.com - September 16 at 5:55 PM
	Can Shares Of MEI Pharma, Inc. (NASDAQ:MEIP) Hit $2.5 - Investor Newswire (NASDAQ:MEIP) www.investornewswire.com - September 14 at 10:22 AM
	Broker Buy/Sell/Hold Updates For MEI Pharma, Inc. (MEIP) - National Daily Press (NASDAQ:MEIP) www.nationaldailypress.com - September 14 at 10:22 AM
	Penny Stock Investors Highly Curious in Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP) www.duncanindependent.com - September 13 at 10:56 AM
	MEI Pharma, Inc. (NASDAQ:MEIP) From The Analysts Point of View - National Daily Press (NASDAQ:MEIP) www.nationaldailypress.com - September 9 at 10:50 AM
	Company Update (NASDAQ:MEIP): MEI Pharma Inc Reports Fiscal Year 2016 Results - Smarter Analyst (NASDAQ:MEIP) www.smarteranalyst.com - September 6 at 6:09 PM
	MEI Pharma Reports Fiscal Year 2016 Results (NASDAQ:MEIP) www.publicnow.com - September 6 at 10:51 AM
	MEI PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:MEIP) biz.yahoo.com - September 2 at 3:25 PM
	MEI Pharma, Inc. (NASDAQ:MEIP) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:MEIP) www.investornewswire.com - August 23 at 6:20 PM
	MEI PHARMA, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities (NASDAQ:MEIP) biz.yahoo.com - August 17 at 6:19 PM
	Will MEI Pharma, Inc. (NASDAQ:MEIP) Hit $2 Price Target? - Investor Newswire (NASDAQ:MEIP) www.investornewswire.com - August 16 at 6:13 PM
	MEI Pharma shares jump 51% in pre-market trade after $20 mln drug deal - MarketWatch (NASDAQ:MEIP) www.marketwatch.com - August 10 at 6:32 PM
	MEI Pharma Inc (NASDAQ:MEIP) & Sunstone Hotel Investors (NYSE:SHO) Stocks to Watch - Money News (press release) (NASDAQ:MEIP) www.newsismoney.com - August 10 at 6:32 PM
	MEI Pharma to Present at Wedbush PacGrow Healthcare Conference (NASDAQ:MEIP) finance.yahoo.com - August 10 at 9:07 AM
	Helsinn partners with MEI Pharma to develop Pracinostat cancer drug (NASDAQ:MEIP) myhealthbowl.com - August 9 at 6:22 PM
	MEI PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a (NASDAQ:MEIP) biz.yahoo.com - August 9 at 9:15 AM
	Mid-Morning Market Update: Markets Edge Lower; Tyson Foods Tops Q3 Expectations (NASDAQ:MEIP) www.stockhouse.com - August 8 at 10:49 AM
	Helsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat … (NASDAQ:MEIP) finance.yahoo.com - August 8 at 10:49 AM
	MEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat (NASDAQ:MEIP) www.streetinsider.com - August 8 at 10:49 AM
	Helsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat for the Treatment of Acute Myeloid Leukemia and Other Hematologic Diseases (NASDAQ:MEIP) www.publicnow.com - August 8 at 10:49 AM
	MEI Pharma shares jump 51% in pre-market trade after $20 mln drug deal (NASDAQ:MEIP) www.marketwatch.com - August 8 at 10:49 AM
	Healthcare Stocks Gaining Limelight- CytRx Corporation (NASDAQ:CYTR), MEI Pharma (NASDAQ:MEIP) - Seneca Globe (NASDAQ:MEIP) www.senecaglobe.com - August 4 at 6:29 PM
	Wedbush Top Analyst Remains Sidelined on MEI Pharma Inc (MEIP) Despite Receiving Breakthrough Therapy ... - Smarter Analyst (NASDAQ:MEIP) www.smarteranalyst.com - August 4 at 6:29 PM
	Wedbush Top Analyst Remains Sidelined on MEI Pharma Inc (MEIP) Despite Receiving Breakthrough Therapy Designation; Here’s Why (NASDAQ:MEIP) www.smarteranalyst.com - August 3 at 6:29 PM
	Active Stocks Notes Wondering in Hotspot- MEI Pharma, Inc. (NASDAQ:MEIP), Texas Roadhouse, Inc. (NASDAQ ... - Seneca Globe (NASDAQ:MEIP) www.senecaglobe.com - August 2 at 6:26 PM
	Symantec Corporation (NASDAQ:SYMC) & MEI Pharma Inc (NASDAQ:MEIP) Stocks in Focus - Money News (press release) (NASDAQ:MEIP) www.newsismoney.com - August 2 at 6:26 PM
	MEI Pharma's (MEIP) Pracinostat Receives FDA Breakthrough Therapy Designation - StreetInsider.com (NASDAQ:MEIP) www.streetinsider.com - August 1 at 10:50 AM
	MEI Pharma's Pracinostat Receives Breakthrough Therapy Designation from FDA for Treatment in Combination with Azacitidine of Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy (NASDAQ:MEIP) www.publicnow.com - August 1 at 8:51 AM
	8:33 am MEI Pharma announces the FDA has granted Breakthrough Therapy Designation for the investigational drug Pracinostat in combination with azacitidine for the treatment of acute myeloid leukemia (NASDAQ:MEIP) finance.yahoo.com - August 1 at 8:33 AM
	Can Shares Of MEI Pharma, Inc. (NASDAQ:MEIP) Hit $2? - Investor Newswire (NASDAQ:MEIP) www.investornewswire.com - July 28 at 9:22 AM
	Tracking Analyst Ratings and Target Projections for: MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP) presstelegraph.com - July 21 at 6:24 PM
	Broker Outlook For MEI Pharma, Inc. (MEIP) - Fiscal Standard (NASDAQ:MEIP) www.fiscalstandard.com - July 21 at 6:24 PM
	Trading Performance and Target Watch for MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP) presstelegraph.com - July 19 at 11:59 AM
	MEI Pharma, Inc. (NASDAQ:MEIP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:MEIP) www.engelwooddaily.com - July 19 at 11:59 AM
	Shares Moving Down on the Week: MEI Pharma, Inc. (NASDAQ:MEIP) - Engelwood Daily (NASDAQ:MEIP) www.engelwooddaily.com - July 17 at 10:27 AM
	Shares Experiencing a Downtrend: MEI Pharma, Inc. (NASDAQ:MEIP) - TGP (NASDAQ:MEIP) telanaganapress.com - July 16 at 9:29 AM
	Stock Volatility Focus for: MEI Pharma, Inc. (NASDAQ:MEIP) - Engelwood Daily (NASDAQ:MEIP) www.engelwooddaily.com - July 12 at 6:24 PM
	MEI Pharma, Inc. (MEIP) Updated Price Targets - FTSE News (NASDAQ:MEIP) www.ftsenews.co.uk - July 12 at 6:24 PM
	Strong Sell Calls For MEI Pharma, Inc. (NASDAQ:MEIP) At 0 - Investor Newswire (NASDAQ:MEIP) www.investornewswire.com - July 12 at 6:24 PM
	MEI Pharma, Inc. (MEIP) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:MEIP) www.fiscalstandard.com - July 10 at 10:22 AM
	MEI Pharma, Inc. (NASDAQ:MEIP) Expected to Reach Highs Of $2 - Investor Newswire (NASDAQ:MEIP) www.investornewswire.com - July 7 at 6:11 PM
	MEI Pharma, Inc. (NASDAQ:MEIP) Company Rating and Target Watch - Telanagana Press (NASDAQ:MEIP) telanaganapress.com - July 1 at 6:08 PM
	Recently Issued Stock Ratings For MEI Pharma, Inc. (MEIP) - Fiscal Standard (NASDAQ:MEIP) www.fiscalstandard.com - July 1 at 6:08 PM
	Share Update and Earnings Review for MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP) presstelegraph.com - June 28 at 10:59 AM
	MEI Pharma, Inc. (NASDAQ:MEIP) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:MEIP) www.engelwooddaily.com - June 28 at 10:59 AM
	Equity Research and Technical Review on MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP) presstelegraph.com - June 28 at 10:59 AM